These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
413 related articles for article (PubMed ID: 8168405)
1. Detection of genetic changes in Barrett's adenocarcinoma and Barrett's esophagus by DNA in situ hybridization and immunohistochemistry. Krishnadath KK; Tilanus HW; Alers JC; Mulder AH; van Dekken H Cytometry; 1994 Feb; 15(2):176-84. PubMed ID: 8168405 [TBL] [Abstract][Full Text] [Related]
2. Accumulation of genetic abnormalities during neoplastic progression in Barrett's esophagus. Krishnadath KK; Tilanus HW; van Blankenstein M; Hop WC; Teijgeman R; Mulder AH; Bosman FT; van Dekken H Cancer Res; 1995 May; 55(9):1971-6. PubMed ID: 7728767 [TBL] [Abstract][Full Text] [Related]
3. Molecular evaluation of ablative therapy of Barrett's oesophagus. Hage M; Siersema PD; Vissers KJ; Steyerberg EW; Haringsma J; Kuipers EJ; van Dekken H J Pathol; 2005 Jan; 205(1):57-64. PubMed ID: 15586364 [TBL] [Abstract][Full Text] [Related]
4. Stepwise radical endoscopic resection of the complete Barrett's esophagus with early neoplasia successfully eradicates pre-existing genetic abnormalities. Peters FP; Krishnadath KK; Rygiel AM; Curvers WL; Rosmolen WD; Fockens P; Ten Kate FJ; van Baal JW; Bergman JJ Am J Gastroenterol; 2007 Sep; 102(9):1853-61. PubMed ID: 17509033 [TBL] [Abstract][Full Text] [Related]
5. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus. Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048 [TBL] [Abstract][Full Text] [Related]
6. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus. Rygiel AM; Milano F; Ten Kate FJ; Schaap A; Wang KK; Peppelenbosch MP; Bergman JJ; Krishnadath KK Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552 [TBL] [Abstract][Full Text] [Related]
7. 17p allelic deletions and p53 protein overexpression in Barrett's adenocarcinoma. Blount PL; Ramel S; Raskind WH; Haggitt RC; Sanchez CA; Dean PJ; Rabinovitch PS; Reid BJ Cancer Res; 1991 Oct; 51(20):5482-6. PubMed ID: 1680552 [TBL] [Abstract][Full Text] [Related]
8. Accumulation of p53 protein in normal, dysplastic, and neoplastic Barrett's oesophagus. Krishnadath KK; Tilanus HW; van Blankenstein M; Bosman FT; Mulder AH J Pathol; 1995 Feb; 175(2):175-80. PubMed ID: 7738712 [TBL] [Abstract][Full Text] [Related]
9. Barrett's adenocarcinomas resemble adenocarcinomas of the gastric cardia in terms of chromosomal copy number changes, but relate to squamous cell carcinomas of the distal oesophagus with respect to the presence of high-level amplifications. Weiss MM; Kuipers EJ; Hermsen MA; van Grieken NC; Offerhaus J; Baak JP; Meuwissen SG; Meijer GA J Pathol; 2003 Feb; 199(2):157-65. PubMed ID: 12533828 [TBL] [Abstract][Full Text] [Related]
10. Apoptosis and cell proliferation in the metaplasia-dysplasia-carcinoma-sequence of Barrett's esophagus. Halm U; Tannapfel A; Breitung B; Breidert M; Wittekind CW; Mössner J Hepatogastroenterology; 2000; 47(34):962-6. PubMed ID: 11020858 [TBL] [Abstract][Full Text] [Related]
11. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study. Sikkema M; Kerkhof M; Steyerberg EW; Kusters JG; van Strien PM; Looman CW; van Dekken H; Siersema PD; Kuipers EJ Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963 [TBL] [Abstract][Full Text] [Related]
12. Clonal analysis of a case of multifocal oesophageal (Barrett's) adenocarcinoma by comparative genomic hybridization. van Dekken H; Vissers CJ; Tilanus HW; Tanke HJ; Rosenberg C J Pathol; 1999 Jul; 188(3):263-6. PubMed ID: 10419593 [TBL] [Abstract][Full Text] [Related]
13. High-grade dysplasia and superficial adenocarcinoma in Barrett's esophagus: histological mapping and expression of p53, p21 and Bcl-2 oncoproteins. Chatelain D; Fléjou JF Virchows Arch; 2003 Jan; 442(1):18-24. PubMed ID: 12536310 [TBL] [Abstract][Full Text] [Related]
14. [Demonstration of clonal heterogeneity in adenocarcinomas on Barrett's esophagus by flow cytometric study of cellular DNA content]. Robaszkiewicz M; Volant A; Hardy E; Nousbaum JB; Calament G; Cauvin JM; Bail JP; Lozach P; Gouerou H Gastroenterol Clin Biol; 1992; 16(6-7):540-6. PubMed ID: 1526415 [TBL] [Abstract][Full Text] [Related]
15. Genomic alterations in malignant transformation of Barrett's esophagus. Riegman PH; Vissers KJ; Alers JC; Geelen E; Hop WC; Tilanus HW; van Dekken H Cancer Res; 2001 Apr; 61(7):3164-70. PubMed ID: 11306503 [TBL] [Abstract][Full Text] [Related]
16. Chromosomal instability in Barrett's esophagus is related to telomere shortening. Finley JC; Reid BJ; Odze RD; Sanchez CA; Galipeau P; Li X; Self SG; Gollahon KA; Blount PL; Rabinovitch PS Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1451-7. PubMed ID: 16896031 [TBL] [Abstract][Full Text] [Related]
17. 3p21, 5q21, 9p21 and 17p13.1 allelic deletions are potential markers of individuals with a high risk of developing adenocarcinoma in Barrett's epithelium without dysplasia. Sanz-Ortega J; Hernández S; Saez MC; Sierra E; Sanz-Ortega G; Torres A; Balibrea JL; Sanz-Esponera J; Merino MJ Hepatogastroenterology; 2003; 50(50):404-7. PubMed ID: 12749233 [TBL] [Abstract][Full Text] [Related]
18. p53 gene mutations in Barrett's epithelium and esophageal cancer. Casson AG; Mukhopadhyay T; Cleary KR; Ro JY; Levin B; Roth JA Cancer Res; 1991 Aug; 51(16):4495-9. PubMed ID: 1868473 [TBL] [Abstract][Full Text] [Related]